WASHINGTON -- The NBA and NHL were among six groups that
turned over documents about their drug-testing policies to the
congressional committee looking into steroids in sports.
The House Government Reform Committee had set Tuesday as a
deadline for getting information about drug programs and test
results. Major League Soccer, the ATP, USA Track & Field and the
U.S. Soccer Federation responded in time, while USA Cycling asked
for and was granted an extension because of a snowstorm near its
The NFL was given until last Friday, and turned in its documents
"Committee investigators are reviewing these documents, and
they are continuing to examine the documents received from the NFL
on Friday," committee chairman Tom Davis of Virginia and ranking
Democrat Henry Waxman of California said in a statement. "We will
withhold comment until our review of documents is complete."
In letters sent to the various sports, the committee asked for
information such as the number of drug tests each year, the number
of positive results and which substances are tested for. The
letters specified that the committee wants "summary information,
and does not require identification of individual players."
"We complied with the request and submitted the information
they requested," NBA spokesman Tim Frank said.
NHL chief legal officer Bill Daly said, "We provided a written
response to Congress providing the information that was requested,
as well as additional relevant materials."
During the committee's 11-hour hearing on steroids in baseball
on March 17, when Mark McGwire, Jose Canseco and commissioner Bud
Selig were among the witnesses, several congressmen suggested that
federal legislation might be needed to oversee drug testing in all
The NHL does not test players for performance-enhancing drugs,
while first-time offenders are suspended for five games in the NBA.
Tennis, cycling and track follow International Olympic Committee
and World Anti-Doping Agency standards, including a minimum
two-year ban for a first offense and a lifetime ban for a second